Sujay Kango

Chief Executive Officer at Tmunity Therapeutics, Inc.

Net worth: - $ as of 2024-01-30

60 year

100 connections

Health Technology

Consumer Services

Health Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Justin File	M	53	MEI PHARMA, INC.	1 years
Tom Glocer	M	63	MERCK & CO., INC.	17 years
Rebecca Roberts	F	71	ABBVIE INC.	6 years
Carl June	M	70	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-
Melody Meyer	F	66	ABBVIE INC.	7 years
Dalton Smart	M	58	MERCK & CO., INC.	15 years
Chirfi Guindo	M	58	MERCK & CO., INC.	13 years
Steven Wood	M	41	MEI PHARMA, INC.	1 years
James Flynn	M	43	MEI PHARMA, INC.	1 years
Caroline Ruiz	F	-	MEI PHARMA, INC.	2 years
Jason Sausser	M	-	MEI PHARMA, INC.	2 years
Steven Graziano	M	-	MERCK & CO., INC.	18 years
Taheer Mehboob Datoo	M	33	MEI PHARMA, INC.	1 years
Judith Li	F	40	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-
Denise Williams	F	-	MERCK & CO., INC.	15 years
Pamela Eisele	F	-	MERCK & CO., INC.	15 years
Beth Seidenberg	M	67	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-
Sanat Chattopadhyay	M	-	MERCK & CO., INC.	15 years
Anne Frese	F	-	MEI PHARMA, INC.	2 years
Patrick M. Gray	M	75	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	5 years
Jorge Conde	M	47	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	5 years
Sean Parker	M	44	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	6 years
Li Ming	M	-	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
N. Coles	M	63	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	5 years
Lawrence Bloch	M	58	INFINITY PHARMACEUTICALS, INC.	11 years
Brian Drazba	M	63	MEI PHARMA, INC.	6 years
Christine Anna White	M	72	MEI PHARMA, INC.	13 years
Fred Hassan	M	78	MERCK & CO., INC.	6 years
Daniel Gold	M	70	MEI PHARMA, INC.	13 years
David J. Scott	M	71	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	-
William Ringo	M	78	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 years
Thomas Wiggans	M	72	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	8 years
Wendy Yarno	F	68	MERCK & CO., INC.	9 years
Vito Palombella	M	61	INFINITY PHARMACEUTICALS, INC.	12 years
Julie Gerberding	M	69	MERCK & CO., INC.	-
Kenneth Bartizal	M	72	MERCK & CO., INC.	20 years
Sriram Ryali	M	43	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	4 years
Tamar Howson	F	75	MEI PHARMA, INC.	4 years
Gwen A. Fyfe	M	72	INFINITY PHARMACEUTICALS, INC.	4 years
Craig Thompson	M	71	MERCK & CO., INC.	10 years
Carole A. Sable	M	62	MERCK & CO., INC.	16 years
Ismail Kola	M	67	MERCK & CO., INC.	4 years
Jaren Madden	F	-	INFINITY PHARMACEUTICALS, INC.	7 years
Jean-Marie Canan	M	68	MERCK & CO., INC.	5 years
Robert Iannone	M	57	MERCK & CO., INC.	6 years
Samuel Agresta	M	51	INFINITY PHARMACEUTICALS, INC.	5 years
Thomas Robert Cech	M	76	MERCK & CO., INC.	-
Magnus Åke Lundberg	M	68	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	13 years
Helen Torley	M	61	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 years
Pablo Cagnoni	M	60	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 years
Carlos Eduardo Represas de Almeida	M	78	MERCK & CO., INC.	-
Leslie Brun	M	72	MERCK & CO., INC.	13 years
Caroline Dorsa	F	64	MERCK & CO., INC.	22 years
Richard Henriques	M	68	MERCK & CO., INC.	27 years
Wendell Wierenga	M	76	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	17 years
Kevan E. Clemens	M	80	MEI PHARMA, INC.	7 years
Christopher M. Lindblom	M	52	INFINITY PHARMACEUTICALS, INC.	-
Natarajan Sethuraman	M	62	MERCK & CO., INC.	10 years
Cheryl Cohen	F	58	MEI PHARMA, INC.	2 years
Steven Goldstone	M	78	MERCK & CO., INC.	6 years
Harry R. Jacobson	M	76	MERCK & CO., INC.	3 years
Paul Goddard	M	74	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	16 years
Antonio J. Grillo-López	M	84	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	11 years
Ofir Moreno	M	-	MEI PHARMA, INC.	12 years
William N. Kelley	M	84	MERCK & CO., INC.	-
David Anstice	M	75	MERCK & CO., INC.	5 years
Eric S. Lander	M	67	INFINITY PHARMACEUTICALS, INC.	10 years
Zane Yang	M	-	MERCK & CO., INC.	3 years
Corey Padovano	M	-	MERCK & CO., INC.	4 years
Ernesto Aycardi	M	61	MERCK & CO., INC.	11 years
Francesco Maria Lavino	M	51	MERCK & CO., INC.	2 years
Christopher Morabito	M	54	MERCK & CO., INC.	4 years
Lisa Escudero	F	62	MERCK & CO., INC.	18 years
Christine Cioffe	F	-	MERCK & CO., INC.	20 years
Louisa Shaw-Marotto	F	56	MERCK & CO., INC.	3 years
Craig Granowitz	M	60	MERCK & CO., INC.	12 years
Sheela Mohan-Peterson	F	61	MERCK & CO., INC.	5 years
Jeffrey Chodakewitz	M	68	MERCK & CO., INC.	4 years
Rita Karachun	F	61	MERCK & CO., INC.	14 years
Barry Goldstein	M	-	MERCK & CO., INC.	5 years
Steven Hubrig Koehler	M	73	MERCK & CO., INC.	2 years
Karen Ling	F	61	MERCK & CO., INC.	6 years
Lee Ausburn	F	-	MERCK & CO., INC.	26 years
Bradley Sheares	M	67	MERCK & CO., INC.	19 years
Richard Murray	M	65	MERCK & CO., INC.	5 years
Martin Duvall	M	62	MERCK & CO., INC.	1 years
Christina Morrison	F	57	MERCK & CO., INC.	4 years
C. Nicholson	M	69	MERCK & CO., INC.	2 years
Lars Kåre Viksmoen	M	75	MERCK & CO., INC.	14 years
Deborah Law	M	-	MERCK & CO., INC.	4 years
David A. Esposito	M	55	MERCK & CO., INC.	13 years
James F. Fuqua	M	-	MERCK & CO., INC.	31 years
Kathleen Metters	M	66	MERCK & CO., INC.	13 years
Anastasia Daifotis	M	-	MERCK & CO., INC.	-
Gregory L. Tewalt	M	-	MERCK & CO., INC.	18 years
Patricia Maxson	M	65	MERCK & CO., INC.	-
Wei Tang	M	-	MERCK & CO., INC.	15 years
Andrew Plump	M	58	MERCK & CO., INC.	-
Terrie Curran	F	55	MERCK & CO., INC.	4 years
Jim Robinson	M	-	MERCK & CO., INC.	5 years

Statistics

Country	Connections	% of total
United States	100	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections